The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Year-End Review 2015 with DelMar Pharmaceuticals, Inc. - Update on Clinical Development, New Indications for VAL-083

SNNLive spoke with Jeffrey A. Bacha, Chairman & CEO of DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) at the LD Micro "Main Event" 2015 in Bel Air, CA.

Share With

Wednesday, January 06, 2016

   

© 2017 Stock News Now